If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,580.00    -50.00 (-0.89%)
Bid:
5,580.00
Ask:
5,590.00
Spread: 10.00 (0.179%)
Market Cap: £2.99b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Director/PDMR Shareholding

3 Aug 2018 12:21

RNS Number : 8022W
Cranswick PLC
03 August 2018
 

Director/PDMR Shareholding

Cranswick plc ("the Company")

The Company has been notified that the following award of LTIP nil-cost options has been made, pursuant to the Cranswick plc Long Term Incentive Plan (the "Scheme"), to certain Directors/Persons Discharging Managerial Responsibility ("PDMR") over ordinary shares of 10 pence each in the Company ("Ordinary Shares"), as follows:

Name

No. of Ordinary Shares subject to Option

Martin Davey

19,100

Adam Couch

38,600

Mark Bottomley

25,500

Jim Brisby

25,500

Chris Aldersley

15,800

The nil-cost options were granted on 1 August 2018 in accordance with the Scheme and are based on a share price of 3293.34 pence per Ordinary Share, being the average quoted market price of the Company's shares on the three dealing days prior to the date of grant.

Each person has also been granted a tax qualifying option over 910 Ordinary Shares at an exercise price of 3293.34 pence per Ordinary Share as part of their award. These tax qualifying options are linked to the LTIP nil-cost options such that, at the time of exercise, to the extent that there is a gain in the tax qualifying option, the LTIP nil-cost option will be forfeited to the value of that gain.

Vesting of the LTIP nil-cost options and tax qualifying options is subject to the achievement of the performance criteria based on growth in EPS (as regards 50% of the awards) and relative Total Shareholder Return (as regards 50% of each award). The targets applying to each element are as follows.

 

Target

EPS

Threshold

Average annual % growth in RPI + 3%

Maximum

Average annual % growth in RPI + 9%

TSR

Threshold

Median

Maximum

Upper decile

 

Enquiries:

Steven Glover, Company Secretary tel: 01482 372000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEAFPDEAEPEFF
Date   Source Headline
18th Jan 20247:00 amRNSThird quarter trading statement
3rd Jan 20247:00 amRNSDirector/PDMR Shareholding
2nd Jan 20243:05 pmRNSTotal Voting Rights
5th Dec 20232:25 pmRNSDirector/PDMR Shareholding
1st Dec 20231:34 pmRNSDirector/PDMR Shareholding
29th Nov 20239:18 amRNSIssue of Equity
21st Nov 20237:00 amRNSInterim Results
1st Nov 20233:21 pmRNSTotal Voting Rights
30th Oct 20239:09 amRNSHolding(s) in Company
5th Oct 202312:18 pmRNSBLOCK LISTING SIX MONTHLY RETURN
5th Oct 202312:15 pmRNSBLOCK LISTING SIX MONTHLY RETURN
5th Oct 202312:10 pmRNSTotal Voting Rights
12th Sep 20232:06 pmRNSDirector/PDMR Shareholding
12th Sep 20232:05 pmRNSDirector/PDMR Shareholding
12th Sep 20232:03 pmRNSDirector/PDMR Shareholding
12th Sep 20232:02 pmRNSDirector/PDMR Shareholding
4th Sep 202310:30 amRNSTotal Voting Rights
29th Aug 20231:58 pmRNSDirectorate Change
29th Aug 202310:56 amRNSDirector/PDMR Shareholding
1st Aug 202312:16 pmRNSTotal Voting Rights
24th Jul 20235:56 pmRNSResult of AGM
24th Jul 20237:00 amRNSFirst quarter trading statement
3rd Jul 20232:04 pmRNSTotal Voting Rights
3rd Jul 20232:03 pmRNSDirector/PDMR Shareholding
3rd Jul 20231:57 pmRNSDirector/PDMR Shareholding
3rd Jul 20231:56 pmRNSDirector/PDMR Shareholding
14th Jun 20238:21 amRNSHolding(s) in Company
5th Jun 20235:18 pmRNSTotal Voting Rights
1st Jun 20234:08 pmRNSDirector/PDMR Shareholding
23rd May 20237:01 amRNSDirector Appointment and Board Changes
23rd May 20237:00 amRNSPRELIMINARY RESULTS
2nd May 202312:56 pmRNSTotal Voting Rights
19th Apr 20232:44 pmRNSBlock listing Interim Review
19th Apr 20232:43 pmRNSBlock listing Interim Review
5th Apr 20239:00 amRNSAdditional Listing
4th Apr 20239:30 amRNSTotal Voting Rights
22nd Mar 20237:30 amRNSDirectorate Change
20th Mar 20231:38 pmRNSHolding(s) in Company
6th Feb 202310:00 amRNSTotal Voting Rights
2nd Feb 20237:00 amRNSThird quarter trading statement
23rd Jan 20239:30 amRNSAdditional Listing
18th Jan 202312:25 pmRNSTotal Voting Rights
6th Jan 202310:57 amRNSDirector/PDMR Shareholding
3rd Jan 202311:43 amRNSDirector/PDMR Shareholding
22nd Dec 202211:20 amRNSCranswick Scrip Dividend Scheme
2nd Dec 20225:47 pmRNSHolding(s) in Company
2nd Dec 20225:07 pmRNSHolding(s) in Company
29th Nov 20227:30 amRNSDirectorship
25th Nov 20221:48 pmRNSHolding(s) in Company
23rd Nov 20223:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.